Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gerszten

Showing results (1-10 of 368) with videos related to

Pageof 37
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Pleiotropic effects of chemokines in vascular lesion developmentRobert E Gerszten
Neurosurgery|September 1, 1995
Intentional cranial deformation: a disappearing form of self-mutilationP C Gerszten, E Gerszten
Clinical Chemistry|August 31, 2006
Biomarker discovery and validationNader Rifai, Robert E Gerszten
Clinical Chemistry|November 24, 2011
Metabolomics and cardiovascular biomarker discoveryEugene P Rhee, Robert E Gerszten
Nature|February 22, 2008
The search for new cardiovascular biomarkersRobert E Gerszten, Thomas J Wang
Cell Metabolism|June 18, 2013
Toward new biomarkers of cardiometabolic diseasesLee D Roberts, Robert E Gerszten
Annual Review of Medicine|January 28, 2020
Omics and Cardiometabolic Disease Risk PredictionUsman A Tahir, Robert E Gerszten
Circulation Research|June 8, 2023
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young IndividualsUsman A Tahir, Robert E Gerszten
The Journal of Clinical Investigation|July 3, 2023
Exercise, exerkines, and cardiometabolic health: from individual players to a team sportJeremy M Robbins, Robert E Gerszten
Circulation|April 26, 2017
Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular DiseaseJ Gustav Smith, Robert E Gerszten
Pageof 37

Showing results (1-10 of 368) with videos related to

Sort By:
Pageof 37
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Pleiotropic effects of chemokines in vascular lesion developmentRobert E Gerszten
Neurosurgery|September 1, 1995
Intentional cranial deformation: a disappearing form of self-mutilationP C Gerszten, E Gerszten
Clinical Chemistry|August 31, 2006
Biomarker discovery and validationNader Rifai, Robert E Gerszten
Clinical Chemistry|November 24, 2011
Metabolomics and cardiovascular biomarker discoveryEugene P Rhee, Robert E Gerszten
Nature|February 22, 2008
The search for new cardiovascular biomarkersRobert E Gerszten, Thomas J Wang
Cell Metabolism|June 18, 2013
Toward new biomarkers of cardiometabolic diseasesLee D Roberts, Robert E Gerszten
Annual Review of Medicine|January 28, 2020
Omics and Cardiometabolic Disease Risk PredictionUsman A Tahir, Robert E Gerszten
Circulation Research|June 8, 2023
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young IndividualsUsman A Tahir, Robert E Gerszten
The Journal of Clinical Investigation|July 3, 2023
Exercise, exerkines, and cardiometabolic health: from individual players to a team sportJeremy M Robbins, Robert E Gerszten
Circulation|April 26, 2017
Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular DiseaseJ Gustav Smith, Robert E Gerszten
Pageof 37